Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Relistor, methylnaltrexone (MNTX) (MOA-728, ONO-3849)
print preview
bookmark
share with colleague
General Information
Company
Progenics Pharmaceuticals Inc.
Description
Peripheral mu opioid receptor (OPRM1; MOR) antagonist
Molecular Target
Mu opioid receptor (OPRM1) (MOR)
Mechanism of Action
Mu opioid receptor antagonist
Latest Stage of Development
Marketed
Indication
Constipation
Partner
Ono Pharmaceutical Co. Ltd.
;
Salix Pharmaceuticals Inc.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information